Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects

Siegfried Kasper, Markus Dötsch, Hermes Kick, Antonio Vieira, Hans-Jürgen Möller
  • European Neuropsychopharmacology, March 1993, Elsevier
  • DOI: 10.1016/0924-977x(93)90290-3
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Hans-Juergen Moeller